How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

New experiments suggest that freezing and thawing on early Earth may have helped primitive cell-like structures grow and evolve. Tiny lipid bubbles behaved very differently depending on their membrane ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

A merge sort uses smaller, ordered lists which are easier to sort and merge than larger lists. It is usually more efficient and quicker than the bubble sort. It is more complex to code. It will still ...